U.S. Physical Therapy (NYSE:USPH) Given New $122.00 Price Target at Barrington Research

U.S. Physical Therapy (NYSE:USPH) had its target price boosted by equities researchers at Barrington Research from $110.00 to $122.00 in a note issued to investors on Friday, Benzinga reports. The firm currently has an “outperform” rating on the stock. Barrington Research‘s price target indicates a potential upside of 22.87% from the stock’s current price.

A number of other research firms have also commented on USPH. Weiss Ratings restated a “hold (c-)” rating on shares of U.S. Physical Therapy in a research note on Wednesday, August 26th. JPMorgan Chase & Co. raised their target price on shares of U.S. Physical Therapy from $90.00 to $95.00 and gave the company an “overweight” rating in a report on Friday, September 11th. Finally, Citigroup restated a “market outperform” rating on shares of U.S. Physical Therapy in a research report on Wednesday, August 19th. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, U.S. Physical Therapy has a consensus rating of “Moderate Buy” and a consensus target price of $104.25.

U.S. Physical Therapy Stock Performance

Shares of U.S. Physical Therapy stock traded up $0.69 during trading on Friday, reaching $99.30. The company’s stock had a trading volume of 56,829 shares, compared to its average volume of 205,026. U.S. Physical Therapy has a 52 week low of $58.19 and a 52 week high of $101.80. The company has a quick ratio of 1.42, a current ratio of 1.42 and a debt-to-equity ratio of 0.56. The business’s 50-day moving average price is $85.91 and its 200-day moving average price is $77.31. The firm has a market cap of $1.48 billion, a PE ratio of -73.55, a P/E/G ratio of 2.75 and a beta of 1.16.

U.S. Physical Therapy (NYSE:USPH) last announced its earnings results on Thursday, November 5th. The company reported $0.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.76 by $0.04. U.S. Physical Therapy had a net margin of 3.60% and a return on equity of 10.19%. The firm had revenue of $222.56 million for the quarter, compared to analyst estimates of $214.48 million. During the same quarter in the prior year, the business posted $0.66 EPS. The business’s revenue was up 12.9% compared to the same quarter last year. Equities analysts forecast that U.S. Physical Therapy will post 2.87 earnings per share for the current year.

Institutional Investors Weigh In On U.S. Physical Therapy

Hedge funds have recently made changes to their positions in the stock. Mitsubishi UFJ Asset Management Co. Ltd. bought a new position in U.S. Physical Therapy in the 2nd quarter valued at approximately $30,000. Allworth Financial LP increased its holdings in shares of U.S. Physical Therapy by 1,341.7% during the third quarter. Allworth Financial LP now owns 346 shares of the company’s stock worth $30,000 after buying an additional 322 shares in the last quarter. Integrated Wealth Concepts LLC bought a new position in shares of U.S. Physical Therapy in the 2nd quarter valued at $33,000. Fulcrum Asset Management LLP bought a new position in shares of U.S. Physical Therapy in the 3rd quarter valued at $35,000. Finally, Sterling Capital Management LLC boosted its holdings in shares of U.S. Physical Therapy by 221.0% during the 3rd quarter. Sterling Capital Management LLC now owns 443 shares of the company’s stock valued at $38,000 after acquiring an additional 305 shares in the last quarter.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc. operates outpatient physical and occupational therapy clinics across the United States. Its clinics provide rehabilitation for musculoskeletal conditions, orthopedic injuries, sports-related injuries and recovery following surgery, along with other therapy services tailored to patients’ needs. Founded in 1990 and headquartered in Houston, Texas, the company also provides industrial injury prevention and related services to employers. Its clinic network serves communities in multiple states, with care delivered through local therapy practices.